Search results
Results from the WOW.Com Content Network
Global Invacom Group Limited: Singapore: SG2E91982768: 21 June 2012 Global Investments Limited: Bermuda: SGXC73602341: 20 December 2006 Global Palm Resources Holdings Limited: Singapore: SG1CD3000003: 29 April 2010 Global Testing Corporation Limited: Singapore: SG1BB4000008: 24 August 2005 Golden Agri-Resources Ltd: Others: MU0117U00026: 9 July ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
The first bid valued the business at £41 billion (£28 per Shire shares paid in Takeda shares plus £16 per share in cash), the second £43 billion (£28.75 per Shire shares paid in Takeda shares plus £16.75 per share in cash) and the third £44 billion (£28 per Shire shares paid in Takeda shares plus £17.75 per share in cash). [37]
In February 2015, AMRI acquired SSCI based in West Lafayette, Indiana. SSCI was founded in 1991, providing comprehensive cGMP solid state chemistry research and analytical services to the pharmaceutical industry. Servicing more than 250 customers a year. [25] [26] In July 2015, the company acquired Gadea Pharmaceutical group for $174 million. [27]
Lupin's businesses encompass the entire pharmaceutical value chain, ranging from branded and generic formulations, APIs, advanced drug delivery systems to biotechnology. . The company's drugs reach 70 countries [22] with a footprint that covers advanced markets such as USA, Europe, Japan, [23] Australia as well as emerging markets including India, the Philippines and South Africa to name a
Mundipharma International Limited is a British multinational research-based pharmaceutical company owned by members of the Sackler family with locations in United Kingdom, Canada, Germany, and Singapore. [2] In Germany, Mundipharma is a subsidiary of Mundipharma International Limited and Mundipharma AG.
This list is based on the Forbes Global 2000, which ranks the world's 2,000 largest publicly traded companies.The Forbes list takes into account a multitude of factors, including the revenue, net profit, total assets and market value of each company; each factor is given a weighted rank in terms of importance when considering the overall ranking.